VANGUARD GROUP INC 13D and 13G filings for Rhythm Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-13 5:13 pm Purchase |
2023-12-29 | 13G | Rhythm Pharmaceuticals, Inc. RYTM |
VANGUARD GROUP INC | 3,226,938 5.460% |
3,226,938 (New Position) |
Filing |